title: Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.
authors.forename: Klaus H
authors.initials: KH
authors.lastname: Metzeler
authors.forename: Stefan
authors.initials: S
authors.lastname: Boeck
authors.forename: Birgit
authors.initials: B
authors.lastname: Christ
authors.forename: Andreas
authors.initials: A
authors.lastname: Hausmann
authors.forename: Hans-Joachim
authors.initials: HJ
authors.lastname: Stemmler
authors.forename: Klaus G
authors.initials: KG
authors.lastname: Parhofer
authors.forename: Helmut
authors.initials: H
authors.lastname: Ostermann
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Hiddemann
authors.forename: Jan
authors.initials: J
authors.lastname: Braess
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics; D000090243:Nucleophosmin; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics
chemical_list: D009687:Nuclear Proteins; D003561:Cytarabine; D000090243:Nucleophosmin; D008942:Mitoxantrone; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3